Key result
This review discusses the known interactions between the ryanodine receptor, triadin, junctin, and calsequestrin, which are critical for normal cardiac muscle function and implicated in CPVT.
This review highlights the critical functional interactions between RyR2, triadin, junctin, and calsequestrin in regulating intracellular calcium release, which is essential for understanding the molecular basis of catecholaminergic polymorphic ventricular tachycardia (CPVT).
Clarifies RyR2 complex interactions in CPVT; leaves open targeted therapies pending prospective validation.
SUMMARY: The contractile function of the heart requires the release of Ca(2+) from intracellular Ca(2+) stores in the sarcoplasmic reticulum (SR) of cardiac muscle cells. The efficacy of Ca(2+) release depends on the amount of Ca(2+) loaded into the Ca(2+) store and the way in which this 'Ca(2+) load' influences the activity of the cardiac ryanodine receptor Ca(2+) release channel (RyR2). The effects of the Ca(2+) load on Ca(2+) release through RyR2 are facilitated by: (i) the sensitivity of RyR2 itself to luminal Ca(2+) concentrations; and (ii) interactions between the cardiac Ca(2+) -binding protein calsequestrin (CSQ) 2 and RyR2, transmitted through the 'anchoring' proteins junctin and/or triadin. Mutations in RyR2 are linked to catecholaminergic polymorphic ventricular tachycardia (CPVT) and sudden cardiac death. The tachycardia is associated with changes in the sensitivity of RyR2 to luminal Ca(2+) . Triadin-, junctin- or CSQ-null animals survive, but their longevity and ability to tolerate stress is compromised. These studies reveal the importance of the proteins in normal muscle function, but do not reveal the molecular nature of their functional interactions, which must be defined before changes in the proteins leading to CPVT and heart disease can be understood. Herein, we discuss known interactions between the RyR, triadin, junctin and CSQ with emphasis on the cardiac isoforms of the proteins. Where there is little known about the cardiac isoforms, we discuss evidence from skeletal isoforms.
No takes yet. Share an insight, caveat, or question.
Dulhunty et al. (2012) conducted a review in Catecholaminergic polymorphic ventricular tachycardia (CPVT) and sudden cardiac death. Interactions between RyR, triadin, junctin, and CSQ was evaluated. This review discusses the known interactions between the ryanodine receptor, triadin, junctin, and calsequestrin, which are critical for normal cardiac muscle function and implicated in CPVT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: